Seeing the Gene and Cell Therapy Translational Divide as an Opportunity

Nathan Yozwiak, head of research at the Mass General Brigham Gene and Cell Therapy Institute, about the need it is seeking to address, how the institute operates, and what it might do to enable the development of bespoke therapies for ultra-rare diseases.